New clinical research demonstrates that lamivudine, a reverse transcriptase inhibitor often used in HIV treatment, prevented disease progression in 25% of patients with metastatic colorectal cancer who were on their fourth line of treatment

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes:

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>